This site is intended for healthcare professionals

Immuno-oncotherapy News 1/2020 Slovak edition

Pembrolizumab for Early Triple-Negative Breast Cancer

Authors: P. Schmid, J. Cortes, L. Pusztai, et. al.

Immuno-oncotherapy News 1/2020 Slovak edition

BACKGROUND Previous trials showed promising antitumor activity and an acceptable safety profile associated with pembrolizumab in patients with early triple-negative breast cancer. Whether the addition of pembrolizumab to neoadjuvant chemotherapy would significantly increase the percentage of patients with early triple-negative breast cancer who have a pathological complete response (defined as no invasive cancer in the…

Zpět

HOME Journal 2/2025

18 | 09 | 2025

Práve vyšlo nové číslo časopisu HOME Journal.

Cystická fibróza 1/2025

07 | 07 | 2025

V júli vyjde prvé tohtoročné číslo časopisu Cystická fibróza.

Antiinfectives News 1/2025

30 | 06 | 2025




Partneři projektu